Nichi-Iko Pharmaceutical Co., Ltd. Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stock of Sagent Pharmaceuticals, Inc.
BusinessWire - Mon Aug 29, 6:58AM CDT
Nichi-Iko Pharmaceutical Co., Ltd. (TSE:4541) ("Nichi-Iko" or "Parent"
SGNT: 21.76 (+0.03)
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sagent Pharmaceuticals, Inc. (SGNT)
GlobeNewswire - Wed Aug 10, 6:00PM CDT
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Sagent Pharmaceuticals, Inc. ("Sagent" or the "Company"
SGNT: 21.76 (+0.03)
Nichi-Iko Pharmaceutical Co., Ltd. Announces Expiration of HSR Waiting Period for Proposed Acquisition of Sagent Pharmaceuticals, Inc.
BusinessWire - Tue Aug 09, 8:25AM CDT
Nichi-Iko Pharmaceutical Co., Ltd. (TSE: 4541) ("Nichi-Iko" or "Parent"
SGNT: 21.76 (+0.03)
Shepard Vision, Inc., a Wholly-Owned Subsidiary of Nichi-Iko Pharmaceutical Co., Ltd, Commences All-Cash Tender Offer of $21.75 Net Per Share to Acquire All Outstanding Shares of Sagent Pharmaceuticals, Inc.
BusinessWire - Mon Aug 01, 8:55AM CDT
Shepard Vision, Inc., a Delaware corporation (the "Purchaser"
SGNT: 21.76 (+0.03)
Generic Drugs Market in Japan between year 2015 to 2019 by Market Research Reports
M2 - Thu May 14, 6:40AM CDT
Our analyst researched the following companies as the key players in the Generic Drugs Market in Japan: Meiji Seika Pharma Co. Ltd., Nichi-Iko Pharmaceutical Co. Ltd., Nipro Pharma Corp., Sawai Pharmaceuticals Co. Ltd., Teva Pharmaceutical Industries Ltd. and Towa Pharmaceutical Co. Ltd.
TEVA: 50.48 (+0.12), GSK: 43.21 (+0.15)